Skip to content
  • ABOUT US
    • What Do We Do?
    • Why Are We Better?
    • Senior Management
    • How To Contact Us
  • TRANSACTIONS
    • Chemical Transactions
    • Life Science Transactions
  • BROADCASTS & PUBLICATIONS
    • Our Broadcasts
    • Our Publications
    • Our Analyses
      • Chemical Industry Analyses
      • Pharmaceutical Industry Analyses
      • Biotechnology Industry Analyses
      • Medical Device Industry Analyses
  • CONFERENCES
    • Chemical Conferences
    • Life Science Conferences
  • INDUSTRY PORTALS
    • ChemicalIndustry.com
    • PharmaIndustry.com
    • MedicalDeviceIndustry.com
  • YOUNG & PARTNERS FORUM
  • ABOUT US
    • What Do We Do?
    • Why Are We Better?
    • Senior Management
    • How To Contact Us
  • TRANSACTIONS
    • Chemical Transactions
    • Life Science Transactions
  • BROADCASTS & PUBLICATIONS
    • Our Broadcasts
    • Our Publications
    • Our Analyses
      • Chemical Industry Analyses
      • Pharmaceutical Industry Analyses
      • Biotechnology Industry Analyses
      • Medical Device Industry Analyses
  • CONFERENCES
    • Chemical Conferences
    • Life Science Conferences
  • INDUSTRY PORTALS
    • ChemicalIndustry.com
    • PharmaIndustry.com
    • MedicalDeviceIndustry.com
  • YOUNG & PARTNERS FORUM

Our Publications

  • Our Broadcasts
  • Our Publications
  • Our Analyses
news2012-05-21T09:00:58+00:00

Chemical M&A Market Continues To Fall (Young & Partners article in ICIS May 21 – 27, 2012)

Young & Partners takes a different view versus bullish predictions of a strong M&A market in 2012 by others

news2012-05-21T09:00:14+00:00

Chemical M&A Market Continues To Slide (Young & Partners article in Chemical Week May 21, 2012)

Description of what has driven the fall in M&A dollar volumes since the fall

news2012-04-18T09:00:03+00:00

Uncertain Outlook for Pharma and Biotech Deals Following ‘Turbulent 2011’ (Young & Partners Article in Pharmaceutical Executive April 18, 2012)

Assessment of the M&A, Equity and Debt Financing and Stock Market in 2011 and what lies ahead

news2012-03-19T09:00:41+00:00

Chemical Financing – Volatile And Challenging (Young & Partners article in ICIS March 19-25, 2012)

Description of the strong investment grade debt, volative high yield debt, and weak equity financing markets

news2012-02-27T09:00:36+00:00

Chemical M&A – A Market In Transition (Young & Partners article in ICIS Feb. 27 to March 4, 2012)

Young & Partners article analyzing movement of the chemical M&A market down from the recent peak

news2021-07-01T19:44:40+00:00

Young & Partners Financial Advisor to Apollo in $1.5 billion Taminco Deal (Feb 15,2012)

Press release announcing Apollo's acquisition of Taminco for $1.5 billion and Young & Partners role as financial advisor to Apollo

digitalstudios2021-06-15T17:01:28+00:00

M&A Falling off the Peak (December 12, 2011 – January 1, 2012 ICIS Chemical Business)

Y&P article in ICIS Chemical Business on industry conditions and the slowdown of the chemical M&A market

digitalstudios2021-06-15T17:05:23+00:00

Young & Partners expands Cross-Border Brazilian Mergers and Acquisition Services in Chemicals and Life Sciences (November 7, 2011)

Y&P press release announcing its Brazilian cross-border M&A joint venture with one of the leading Brazilian investment banks.

digitalstudios2021-06-15T17:04:06+00:00

Pharma and Biotech in Turbulent Waters – Young & Partners (Pharma Exec November 2011 Issue)

Annual Y&P article in Pharmaceutical Executive on the life science business, M&A and financial trends

digitalstudios2021-06-15T19:08:48+00:00

Japanese Chemical Mergers and Acquisitions Activities Focused on External Opportunities (October 24, 2011 ICIS Chemical Business)

Y&P description of the evolution of Japanese Chemical company M&A activity in ICIS Chemical Business

Previous141516Next

DISCLAIMER

JOIN OUR MAILING LIST

© YOUNG & PARTNERS LLC   |   535 Fifth Avenue, 4th Floor, New York, New York 10017 | 212-682-5555

Page load link
Go to Top